BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27183113)

  • 1. The Expression of BTLA Was Increased and the Expression of HVEM and LIGHT Were Decreased in the T Cells of Patients with Rheumatoid Arthritis [corrected].
    Yang B; Huang Z; Feng W; Wei W; Zhang J; Liao Y; Li L; Liu X; Wu Z; Cai B; Bai Y; Wang L
    PLoS One; 2016; 11(5):e0155345. PubMed ID: 27183113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of BTLA and HVEM Expression on Circulating CD4
    Song HF; Chen XJ; Tang PJ; Xu P; Huang ZY; Wang XF
    Viral Immunol; 2022 May; 35(4):291-302. PubMed ID: 35196150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and anatomical distribution of BTLA and its ligand HVEM in rheumatoid synovium.
    Shang Y; Guo G; Cui Q; Li J; Ruan Z; Chen Y
    Inflammation; 2012 Jun; 35(3):1102-12. PubMed ID: 22179929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4
    Liu J; Li J; He M; Zhang GL; Zhao Q
    J Immunol Res; 2018; 2018():4561571. PubMed ID: 30116751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-based regimen promotes inhibitory costimulatory signal of HVEM/BTLA/CD160/LIGHT pathway in allo-renal recipients.
    Bai Y; Shi Y; Li Y; Cai B; Zou Y; Wang L
    Transpl Immunol; 2013 Jan; 28(1):38-47. PubMed ID: 23165214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTLA-HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish.
    Shi W; Shao T; Li JY; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Immunol; 2019 Nov; 203(9):2425-2442. PubMed ID: 31562209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors.
    Sun WZ; Lin HW; Chen WY; Chien CL; Lai YL; Chen J; Chen YL; Cheng WF
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
    Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
    Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.
    Steinberg MW; Huang Y; Wang-Zhu Y; Ware CF; Cheroutre H; Kronenberg M
    PLoS One; 2013; 8(10):e77992. PubMed ID: 24205057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and Significance of BTLA and Its Ligand HVEM in Patients with Chronic Myelomonocytic Leukemia].
    Li C; Geng SX; Li MM; Su F; Chen XM; Deng CX; Huang X; Lai PL; Weng JY; DU X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):56-62. PubMed ID: 32027253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of the costimulatory molecule BTLA in synovial tissues from rheumatoid arthritis patients].
    Shang YJ; Cui QF; Li JL; Guo GN; Zhu WY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):643-6. PubMed ID: 22691359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression.
    Wakeley ME; Armstead BE; Gray CC; Tindal EW; Heffernan DS; Chung CS; Ayala A
    Front Med (Lausanne); 2023; 10():1176602. PubMed ID: 37305124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
    Cai G; Freeman GJ
    Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of the BTLA/HVEM Regulatory Network in the Circulation in Primary Sjögren's Syndrome.
    Small A; Cole S; Wang JJ; Nagpal S; Hao LY; Wechalekar MD
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35159987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Xinfeng Capsule improves cardiopulmonary function of knee osteoarthritis rats by BTLA-HVEM signaling pathway to induce Treg immune tolerance].
    Cheng YY; Liu J; Feng YX; Liu L; Wan L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1133-7. PubMed ID: 23127399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
    Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
    Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer.
    Demerlé C; Gorvel L; Olive D
    Front Oncol; 2021; 11():682007. PubMed ID: 34532285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.